Human tissue kallikreins: A road under construction

被引:43
作者
Emami, Nashmil
Diamandis, Eleftherios P.
机构
[1] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada
[2] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
关键词
human tissue kallikreins; serine proteases; PSA; proteolytic cascades; biomarkers; skin desquamation; semen liquefaction; tumor growth; tumor invasion; angiogenesis;
D O I
10.1016/j.cca.2007.02.023
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: The human tissue kallikrein gene family, located at chromosome 19q13.4, is the largest contiguous family of proteases in the human genome. The locus encodes all 15 members of the family, 13 of which have been reported as potential biomarkers for several carcinomas and other non-neoplastic diseases. Kallikreins are expressed by a wide range of tissues and implicated in a number of physiological functions, including skin desquamation, semen liquefaction, neural plasticity and the regulation of blood pressure. Kallikrein function is regulated at various levels, including transcription, translation and post-translation. The proteolytic activity of kallikreins is believed to be cascade mediated and may crosstalk with other proteases. These cascades are highly regulated through a series of feedback loops, inhibitors, (auto) degradation and internal cleavage. Uncontrolled proteolytic activity of kallikreins is implicated in a large number of neoplastic and non-neoplastic pathological conditions. Conclusions: As our understanding of their regulatory and functional mechanisms continues to expand, kallikreins are expected to become novel targets for the design of new therapeutics. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:78 / 84
页数:7
相关论文
共 63 条
[1]   General considerations for proteolytic cascades [J].
Amour, A ;
Bird, M ;
Chaudry, L ;
Deadman, J ;
Hayes, D ;
Kay, C .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2004, 32 :15-16
[2]   Substrate specificity of human kallikrein 6 - Salt and glycosaminoglycan activation effects [J].
Angelo, PF ;
Lima, AR ;
Alves, FM ;
Blaber, SI ;
Scarisbrick, IA ;
Blaber, M ;
Juliano, L ;
Juliano, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (06) :3116-3126
[3]   Implications of protease M/neurosin in myelination during experimental demyelination and remyelination [J].
Bando, Yoshio ;
Ito, Shinji ;
Nagai, Yoshiko ;
Terayama, Ryuji ;
Kishibe, Mari ;
Jiang, Ying-Ping ;
Mitrovic, Branka ;
Takahashi, Takayuki ;
Yoshida, Shigetaka .
NEUROSCIENCE LETTERS, 2006, 405 (03) :175-180
[4]   Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system [J].
Bernett, MJ ;
Blaber, SI ;
Scarisbrick, IA ;
Dhanarajana, P ;
Thomspon, SM ;
Blaber, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (27) :24562-24570
[5]   The emerging roles of human tissue kallikreins in cancer [J].
Borgoño, CA ;
Diamandis, EP .
NATURE REVIEWS CANCER, 2004, 4 (11) :876-890
[6]  
Borgoño CA, 2004, MOL CANCER RES, V2, P257
[7]  
BORGONO CA, 2006, J BIOL CHEM
[8]   A proteolytic cascade of kallikreins in the stratum corneum [J].
Brattsand, M ;
Stefansson, K ;
Lundh, C ;
Haasum, Y ;
Egelrud, T .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 124 (01) :198-203
[9]   The kallikrein-kinin system in humans [J].
Campbell, DJ .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2001, 28 (12) :1060-1065
[10]   Development of recombinant inhibitors specific to human kallikrein 2 using phage-display selected substrates [J].
Cloutier, SM ;
Kündig, C ;
Felber, LM ;
Fattah, OM ;
Chagas, JR ;
Gygi, CM ;
Jichlinski, P ;
Leisinger, HJ ;
Deperthes, D .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2004, 271 (03) :607-613